Abstract
[Tic4]EM1 and [Tic4]EM2, new endomorphins (EMs) analogues, caused relaxation of rat aorta rings precontracted with phenylphrine in a concentration-dependent manner and were 240- to 370-fold more potent than EMs. This effect was inhibited by endothelium removal or by incubation with NO synthase inhibitor L-NNA or opioid receptor antagonist naloxone. The results demonstrate that [Tic4]EMs have NO- and endothelium-dependent vasorelaxant effects which are mediated by the opioid receptor.
Keywords: tic, endomorphins, opioid, vasorelaxant response, rat aorta rings
Protein & Peptide Letters
Title: [TIC4]Endomorphins, Analogues of Endomorphins, Have Significantly Enhanced Vasorelaxant Effects in Rat Aorta Rings
Volume: 12 Issue: 4
Author(s): Qian-Yu Zhao, Qiang Chen, Yun Feng, Xin Lin and Rui Wang
Affiliation:
Keywords: tic, endomorphins, opioid, vasorelaxant response, rat aorta rings
Abstract: [Tic4]EM1 and [Tic4]EM2, new endomorphins (EMs) analogues, caused relaxation of rat aorta rings precontracted with phenylphrine in a concentration-dependent manner and were 240- to 370-fold more potent than EMs. This effect was inhibited by endothelium removal or by incubation with NO synthase inhibitor L-NNA or opioid receptor antagonist naloxone. The results demonstrate that [Tic4]EMs have NO- and endothelium-dependent vasorelaxant effects which are mediated by the opioid receptor.
Export Options
About this article
Cite this article as:
Zhao Qian-Yu, Chen Qiang, Feng Yun, Lin Xin and Wang Rui, [TIC4]Endomorphins, Analogues of Endomorphins, Have Significantly Enhanced Vasorelaxant Effects in Rat Aorta Rings, Protein & Peptide Letters 2005; 12 (4) . https://dx.doi.org/10.2174/0929866053765743
DOI https://dx.doi.org/10.2174/0929866053765743 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Nanostructural Hybrid Sensitizers for Photodynamic Therapy
Current Pharmaceutical Design Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Current Topics in Medicinal Chemistry Controlling Apoptosis by Inhibition of Caspases
Current Medicinal Chemistry Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets The New Perspectives on Genetic Studies of Type 2 Diabetes and Thyroid Diseases
Current Genomics Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases
Current Pharmaceutical Design Formulation and Assessment of In Vivo Anti-Inflammatory Potential of Omega-3-Fatty Acid Loaded Self Emulsifying Nanoemulsion
Current Nanomedicine C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function
Inflammation & Allergy - Drug Targets (Discontinued) Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective
Anti-Cancer Agents in Medicinal Chemistry Functional Neuroimaging in Memory and Memory Disturbances
Current Medical Imaging A Review on the Use of Statins and Tocotrienols, Individually or in Combination for the Treatment of Osteoporosis
Current Drug Targets Current Advances in Therapy for Metastatic Melanoma
Current Cancer Therapy Reviews It Takes Two to Tango: The Structure and Function of LIM, RING, PHD and MYND Domains
Current Pharmaceutical Design Cyclodepsipeptides - Potential Drugs and Lead Compounds in the Drug Development Process
Current Medicinal Chemistry Modulation of Mitochondrial Permeability Transition in Ischemia-Reperfusion Injury of the Heart. Advantages and Limitations
Current Medicinal Chemistry Patent Selections:
Recent Patents on Drug Delivery & Formulation